Next Article in Journal
Nonspecific Feelings Expected and Experienced during or Immediately after Electroacupuncture: A Pilot Study in a Teaching Situation
Next Article in Special Issue
Current Usage of Traditional Chinese Medicine for Breast Cancer—A Narrative Approach to the Experiences of Women with Breast Cancer in Australia—A Pilot Study
Previous Article in Journal
Antimicrobial, Antioxidant, and Cytotoxic Activities of Ocimum forskolei and Teucrium yemense (Lamiaceae) Essential Oils
Previous Article in Special Issue
Ganoderma spp.: A Promising Adjuvant Treatment for Breast Cancer

Dietary Isoflavones and Breast Cancer Risk

Department of Biology, Montclair State University, 1 Normal Avenue, Montclair, NJ 07043, USA
Author to whom correspondence should be addressed.
Academic Editors: Sivarama Vinjamury and Elizabeth Sommers
Medicines 2017, 4(2), 18;
Received: 20 February 2017 / Revised: 22 March 2017 / Accepted: 24 March 2017 / Published: 7 April 2017
(This article belongs to the Special Issue Complementary and Alternative Medicine for Cancer Patients)
Breast cancer is the deadliest neoplasm in women globally, resulting in a significant health burden. In many cases, breast cancer becomes resistant to chemotherapy, radiation, and hormonal therapies. It is believed that genetics is not the major cause of breast cancer. Other contributing risk factors include age at first childbirth, age at menarche, age at menopause, use of oral contraceptives, race and ethnicity, and diet. Diet has been shown to influence breast cancer incidence, recurrence, and prognosis. Soy isoflavones have long been a staple in Asian diets, and there appears to be an increase, albeit modest, compared to Asian populations, in soy consumption among Americans. Isoflavones are phytoestrogens that have antiestrogenic as well as estrogenic effects on breast cancer cells in culture, in animal models, and in clinical trials. This study will investigate anticancer and tumor promoting properties of dietary isoflavones and evaluate their effects on breast cancer development. Furthermore, this work seeks to elucidate the putative molecular pathways by which these phytochemicals modulate breast cancer risk by synergizing or antagonizing the estrogen receptor (ER) and in ER-independent signaling mechanisms. View Full-Text
Keywords: diet; phytoestrogens; isoflavones; soy; breast cancer diet; phytoestrogens; isoflavones; soy; breast cancer
Show Figures

Figure 1

MDPI and ACS Style

Ziaei, S.; Halaby, R. Dietary Isoflavones and Breast Cancer Risk. Medicines 2017, 4, 18.

AMA Style

Ziaei S, Halaby R. Dietary Isoflavones and Breast Cancer Risk. Medicines. 2017; 4(2):18.

Chicago/Turabian Style

Ziaei, Samira, and Reginald Halaby. 2017. "Dietary Isoflavones and Breast Cancer Risk" Medicines 4, no. 2: 18.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop